Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom.

Dibonaventura MD, Chandran A, Hsu MA, Bushmakin A.

Int J Womens Health. 2013 May 24;5:261-9. doi: 10.2147/IJWH.S39027.

2.

Impact of the severity of vasomotor symptoms on health status, resource use, and productivity.

Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, Dibonaventura M, Racketa J.

Menopause. 2013 May;20(5):518-24. doi: 10.1097/GME.0b013e31827d38a5.

PMID:
23403500
3.

A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.

Ding B, DiBonaventura M, Karlsson N, Bergström G, Holmgren U.

Int J Chron Obstruct Pulmon Dis. 2017 Feb 7;12:529-539. doi: 10.2147/COPD.S114085.

4.

The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.

DiBonaventura M, Luo X, Moffatt M, Bushmakin AG, Kumar M, Bobula J.

J Womens Health (Larchmt). 2015 Sep;24(9):713-22. doi: 10.1089/jwh.2014.5177.

PMID:
26199981
5.

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom.

Dibonaventura MD, Prior M, Prieto P, Fortea J.

Clin Exp Gastroenterol. 2012;5:203-12. doi: 10.2147/CEG.S35568.

6.

A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.

Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo S; Collaborative Group for Research of the Climacteric in Latin America (REDLINC)..

Menopause. 2011 Jul;18(7):778-85. doi: 10.1097/gme.0b013e318207851d.

PMID:
21407137
7.

Vasomotor symptoms and osteoporosis in Korean postmenopausal women.

Ryu KJ, Park HT, Kim YJ, Yi KW, Shin JH, Hur JY, Kim T.

Maturitas. 2016 May;87:27-32. doi: 10.1016/j.maturitas.2016.02.007.

PMID:
27013285
8.

The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries.

Vietri J, Prajapati G, El Khoury AC.

BMC Gastroenterol. 2013 Jan 17;13:16. doi: 10.1186/1471-230X-13-16.

9.

Duration of menopausal vasomotor symptoms over the menopause transition.

Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC; Study of Women's Health Across the Nation..

JAMA Intern Med. 2015 Apr;175(4):531-9. doi: 10.1001/jamainternmed.2014.8063.

10.

Vasomotor Symptoms and Quality of Life Among Veteran and Non-Veteran Postmenopausal Women.

Katon JG, Gray KE, Gerber MR, Harrington LB, Woods NF, Weitlauf JC, Bean-Mayberry B, Goldstein KM, Hunt JR, Katon WJ, Haskell SG, McCutcheon SJ, Gass ML, Gibson CJ, Zephyrin LC.

Gerontologist. 2016 Feb;56 Suppl 1:S40-53. doi: 10.1093/geront/gnv104.

PMID:
26220418
11.

Burden of peripheral arterial disease in Europe and the United States: a patient survey.

Marrett E, DiBonaventura Md, Zhang Q.

Health Qual Life Outcomes. 2013 Oct 22;11:175. doi: 10.1186/1477-7525-11-175.

12.

Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.

Gupta S, Kwan P, Faught E, Tsong W, Forsythe A, Ryvlin P.

Epilepsy Behav. 2016 Feb;55:146-56. doi: 10.1016/j.yebeh.2015.12.018.

13.

Depression, quality of life, work productivity, resource use, and costs among women experiencing menopause and hot flashes: a cross-sectional study.

Dibonaventura MD, Wagner JS, Alvir J, Whiteley J.

Prim Care Companion CNS Disord. 2012;14(6). pii: PCC.12m01410. doi: 10.4088/PCC.12m01410.

14.

The humanistic and economic burden associated with increasing body mass index in the EU5.

Gupta S, Richard L, Forsythe A.

Diabetes Metab Syndr Obes. 2015 Jul 22;8:327-38. doi: 10.2147/DMSO.S83696.

15.

Incremental direct and indirect costs of untreated vasomotor symptoms.

Sarrel P, Portman D, Lefebvre P, Lafeuille MH, Grittner AM, Fortier J, Gravel J, Duh MS, Aupperle PM.

Menopause. 2015 Mar;22(3):260-6. doi: 10.1097/GME.0000000000000320.

PMID:
25714236
16.

Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.

Umland EM.

J Manag Care Pharm. 2008 Apr;14(3 Suppl):14-9. Review.

17.

Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries.

Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG.

Rheumatology (Oxford). 2014 May;53(5):937-47. doi: 10.1093/rheumatology/ket463.

PMID:
24489012
18.

Vasomotor symptoms and the homeostatic model assessment of insulin-resistance in Korean postmenopausal women.

Kwon DH, Lee JH, Ryu KJ, Park HT, Kim T.

Obstet Gynecol Sci. 2016 Jan;59(1):45-9. doi: 10.5468/ogs.2016.59.1.45.

19.

Menopausal vasomotor symptoms are associated with poor self-assessed work ability.

Gartoulla P, Bell RJ, Worsley R, Davis SR.

Maturitas. 2016 May;87:33-9. doi: 10.1016/j.maturitas.2016.02.003.

PMID:
27013286
20.

Moderate-Severe Vasomotor Symptoms Are Associated with Moderate-Severe Depressive Symptoms.

Worsley R, Bell RJ, Gartoulla P, Robinson PJ, Davis SR.

J Womens Health (Larchmt). 2017 Mar 6. doi: 10.1089/jwh.2016.6142. [Epub ahead of print]

PMID:
28263691

Supplemental Content

Support Center